期刊名称:BMC MOLECULAR AND CELL BIOLOGY
期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Aims and scope
BMC Molecular and Cell Biology, formerly known as BMC Cell Biology, is an open access journal that considers articles on all aspects of both eukaryotic and prokaryotic cell and molecular biology, including structural and functional cell biology, DNA and RNA in a cellular context and biochemistry, as well as research using both the experimental and theoretical aspects of physics to study biological processes and investigations into the structure of biological macromolecules.
Open access
All articles published by BMC Molecular and Cell Biology are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
As authors of articles published in BMC Molecular and Cell Biology you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BMC license agreement.
For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BMC can accommodate non-standard copyright lines. Please contact us if further information is needed.
Article-processing charges
Open access publishing is not without costs. BMC Molecular and Cell Biology therefore levies an article-processing charge of £1570.00/$2290.00/€1870.00 for each article accepted for publication, plus VAT or local taxes where applicable.
If the corresponding author's institution participates in our open access membership program, some or all of the publication cost may be covered (more details available on the membership page). We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.
BMC provides a free open access funding support service to help authors discover and apply for article processing charge funding. Visit our OA funding and policy support page to view our list of research funders and institutions that provide funding for APCs, and to learn more about our email support service.
Indexing services
The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink.
We are working closely with relevant indexing services including PubMed Central and Web of Science (Clarivate Analytics) to ensure that articles published in BMC Molecular and Cell Biology will be available in their databases when appropriate.
Peer-review policy
Peer-review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the relevant research area assess submitted manuscripts for originality, validity and significance to help editors determine whether the manuscript should be published in their journal. You can read more about the peer-review process here.
BMC Molecular and Cell Biology operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.
The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.
Manuscripts submitted to BMC Molecular and Cell Biology are assessed by our editors and/or peer reviewers. Overall editorial responsibility for the journal is with the Executive Editor. Section Editors provide oversight for manuscripts submitted to their section with Associate Editors acting as handling editors.
BMC Molecular and Cell Biology is part of the BMC series which publishes subject-specific journals focused on the needs of individual research communities across all scientific and clinical disciplines. We do not make editorial decisions on the basis of the interest of a study or its likely impact. Studies must be scientifically valid; for research articles this includes a scientifically sound research question, the use of suitable methods and analysis, and following community-agreed standards relevant to the research field.
Specific criteria for other article types can be found in the submission guidelines.
BMC series - open, inclusive and trusted.
Editorial policies
All manuscripts submitted to BMC Molecular and Cell Biology should adhere to BioMed Central's editorial policies.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Instructions to Authors
Our 3-step submission process
-
Before you submit
Now you’ve identified a journal to submit to, there are a few things you should be familiar with before you submit.
-
Ready to submit
To give your manuscript the best chance of publication, follow these policies and formatting guidelines.
-
Submit and promote
After acceptance, we provide support so your article gains maximum impact in the scientific community and beyond.
Please note that manuscript can only be submitted by an author of the manuscript and may not be submitted by a third party.
Submit manuscript
Editorial Board
Editor
Alison Cuff, BioMed Central, Germany
Manuscript Editor
Dylan Smith, BioMed Central, UK
Assistant Editor
Alexandria Latto, BioMed Central, UK
Section Editors
Matthias Falk, Lehigh University, USA Andrew Koff, Memorial Sloan-Kettering Cancer Center, USA Xuejun Jiang, Memorial Sloan-Kettering Cancer Center, USA
Associate Editors Azlina Ahmad, Universiti Sains Malaysia, Malaysia Maria Balda, University College London, UK Tamas Balla, National Institutes of Health, USA Daniela Barilla, University of York, UK Andrea Bernini, University of Siena, Italy Harris Bernstein, National Institute of Diabetes and Digestive and Kidney Diseases, USA Angelika Böttger, Ludwig Maxilians University Munich, Germany Dave Boucher, University of York, United Kingdom Claudio Brancolini, Universita degli Studi di Udine, Italy Konrad Bussow, Helmholtz Centre for Infection Research, Germany Matteo Castelli, Università Vita-Salute San Raffaele, Italy Kishore Challagundla, University of Nebraska Medical Center, USA Jinghai Chen, Zhejiang University, China J. Don Chen, Rutgers-Robert Wood Johnson Medical School, USA Chang Y Chung, Vanderbilt University School of Medicine, USA Paul Clarke, University of Dundee, UK Damien Coudreuse, Institute of Genetics and Development of Rennes, France Remus T. Dame, Leiden University, Netherlands William Dauer, Columbia University, USA Eros Di Giorgio, University of Udine, Italy Alessandro Didonna, University of California San Francisco, USA Georgina Ellison, Kings College London, UK Chengming Fan, Central South University, China Paulo Ferreira, Duke University Medical Center, USA Slawomir Filipek, University of Warsaw, Poland Paul Fogg, University of York, United Kingdom Maarten Fornerod, The Netherlands Cancer Institute, Netherlands Larry Gerace, The Scripps Research Institute, USA Lorenza Gonzalez-Mariscal, Center for Research and Advanced Studies, Mexico Joel M Goodman, University of Texas Southwestern Medical School, USA John Goss, Wellesley College, United States Marie-Jose Goumans, Leiden University Medical Center, Netherlands Einar Hallberg, Stockholm University, Sweden Naohiro Hashimoto, National Institute for Longevity Sciences, Japan Sudan He, Soochow University, China Jennifer Hirst, University of Cambridge, UK Adriana Ibelli, Embrapa Suínos e Aves, Brazil Gabriel Ichim, Centre de Recherché en Cancerologie de Lyon, France Kazuhisa Iwabuchi, Juntendo University, Japan Jean X Jiang, University of Texas Health Science Center, USA Jason King, University of Sheffield, UK Janesh Kumar, National Centre for Cell Science, India Adam Kwiatkowski, University of Pittsburgh School of Medicine, USA Leticia Miranda Santos Lery, Instituto Oswaldo Cruz (IOC), Brazil Rudolf E Leube, RWTH Aachen University, Germany Rong Li, John Hopkins School of Medicine, USA Tracey A Martin, Cardiff University, UK Karl Matter, University College London, UK Liam McGuffin, The University of Reading, UK Rossana Melo, Federal University of Juiz de Fora, Brazil Andreas Merdes, CNRS, France Massimo Micaroni, University of Gothenburg, Sweden Christian Morsczeck, University Hospital Regensburg, Germany Antoine Muchir, Institute of Myology, UPMC, France Douglas Muench, University of Calgary, Canada Naoshad Muhammad, Washington University in St. Louis, United States Brona Murphy, Royal College of Surgeons in Ireland Kirk Mykytyn, Ohio State University, USA Hannu Myllykallio, Ecole Polytechnique, France Elena Nadezhdina, Institute of Protein Research of Russian Academy of Science, Russian Federation Pablo Ivan Nikel, The Novo Nordisk Foundation Center for Biosustainability, Denmark Sergio Oddi, University of Teramo, Italy Dulal Panda, Indian Institute of Technology, India Swaroop Kumar Pandey, Ben-Gurion University of the Negev, Israel Issidora Papassideri, University of Athens, Greece Louis Penning, Utrecht University, Netherlands Marek Postula, Medical University of Warsaw, Poland Filippo Prischi, University of Essex, UK Tessa Quax, University of Freiburg, Germany Modesto Redrejo-Rodríguez, Universidad Autónoma de Madrid & Instituto de Investigaciones, Spain Francisco Rivero, University of Hull, UK Nicholas Robinson, Lancaster University, UK Karin Romisch, Saarland University, Germany Salvatore De Rosa, Magna Graecia University, Italy Gabriele Saretzki, Newcastle University Institute for Ageing, UK Qunxin She, University of Copenhagen, Denmark Alex Shimura Yamashita, Johns Hopkins University, USA Elias Spiliotis, Drexel University, USA Theresia Stradal, University of Muenster, Germany Paul Steimle, University of North Carolina at Greensboro, USA Ghanshyam Swarup, Centre for Cellular and Molecular Biology, India Shi-Cong Tao, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, China Mohammad Tarique, University of Miami, USA Paolo Tortora, Università di Milano – Bicocca, Italy Chao Tu, The Second Xiangya Hospital, Central South University, China Francois Vallette, Université de Nantes, France Hua Wang, Memorial Sloan Kettering Cancer Center, USA Jim Warwicker, University of Manchester Manchester Institute of Biotechnology, UK Christian Widmann, University of Lausanne, Switzerland Sjoerd van Wijk, Institute for Experimental Cancer Research in Paediatrics, Goethe-University, Germany David Winkler, La Trobe University, Australia Xuebiao Yao, Morehouse School of Medicine, USA Kyoko Yokomori, University of California Irvine, USA
Editorial Advisors
Ueli Aebi ,University of Basel, Switzerland Tetsu Akiyama, University of Tokyo, Japan David Andrews, McMaster University, Canada Francis A Barr, University of Liverpool, UK David Brautigan, University of Virginia School of Medicine, USA Joan S Brugge, Harvard University, USA Lewis Cantley, Harvard Institutes of Medicine, USA Bruce Demple, Harvard School of Public Health, USA Elaine Elion, Harvard Medical School, USA Scott Emr, Howard Hughes Medical Institute & University of California, San Diego, USA Gary Firestone, University of California at Berkeley, USA Peter A Greer, Queen's University Cancer Research Institute, Canada Gregg G Gundersen, Columbia University, USA Iswar K Hariharan, University of California, Berkeley, USA Mitsuhiko Ikura, Ontario Cancer Institute, Canada Tohru Kataoka, Kobe University Graduate School of Medicine, Japan Cynthia L Kenyon, University of California, USA Jeanne Lawrence, University of Massachusetts Medical School, USA Gregory A Matera, The University of North Carolina at Chapel Hill, USA Paul Matsudaira, Massachusetts Institute of Technology, USA Fumio Matsumura, Rutgers University, USA Graeme Milligan, University of Glasgow, UK Keith E Mostov, University of California, San Francisco, USA Walter Neupert, Ludwig-Maximilians-Universitat, Germany Bjorn Olsen, Harvard Medical School, USA Michele Pagano, Howard Hughes Medical Institute, USA Suzanne Pfeffer, Stanford University School of Medicine, USA Jeff Rathmell, Duke University, USA Joseph Schlessinger, Yale University School of Medicine, USA Tim Stearns, Stanford University, USA Yoshimi Takai, Kobe University Graduate School of Medicine, Japan Thomas von Zglinicki, Institute for Ageing and Health, Newcastle University, UK Yu-Li Wang, Carnegie Mellon University, USA Karsten Weis, University of California, Berkeley, USA Jonathan Weissman, Howard Hughes Medical Institute & University of California, USA Toshio Yanagida, Graduate School of Frontier Biosciences, Osaka University, Japan Junying Yuan, Harvard Medical School, USA
|